Novel therapeutic modalities and drug delivery – erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations
H Xu, C He, Y Liu, J Jiang, T Ma - Artificial cells, nanomedicine …, 2018 - Taylor & Francis
The aim of this study to develop galactosylated erlotinib liposomes for treatment of lung
cancer. The liposomes were prepared by using solvent evaporation method. Various …
cancer. The liposomes were prepared by using solvent evaporation method. Various …
Novel therapeutic modalities and drug delivery-erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.
H Xu, C He, Y Liu, J Jiang, T Ma - Artificial Cells, Nanomedicine …, 2017 - europepmc.org
The aim of this study to develop galactosylated erlotinib liposomes for treatment of lung
cancer. The liposomes were prepared by using solvent evaporation method. Various …
cancer. The liposomes were prepared by using solvent evaporation method. Various …
Novel therapeutic modalities and drug delivery-erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations
H Xu, C He, Y Liu, J Jiang, T Ma - Artificial cells …, 2018 - pubmed.ncbi.nlm.nih.gov
The aim of this study to develop galactosylated erlotinib liposomes for treatment of lung
cancer. The liposomes were prepared by using solvent evaporation method. Various …
cancer. The liposomes were prepared by using solvent evaporation method. Various …